-

Licensing Deals Made in Biotechnology 2020-2025: A Comprehensive Review of the Top Licensing Deals & Active Dealmakers - Identify Assets and Deal Terms for Each Transaction - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Licensing Deals in Biotechnology 2020-2025" report has been added to ResearchAndMarkets.com's offering.

Licensing Deals in Biotechnology provides a detailed understanding and analysis of how and why companies enter licensing deals. Fully revised and updated, the report provides details of licensing deals from 2020 to 2025.

Licensing Deals in Biotechnology provides the reader with the following key benefits:

  • Understand deal trends since 2020
  • Browse licensing deals
  • Benchmark analysis - identify market value of transactions
  • Financials terms - upfront, milestone, royalties
  • Directory of deals by company A-Z, therapy focus and technology type
  • Leading deals by value
  • Most active dealmakers
  • Identify assets and deal terms for each transaction
  • Access contract documents - insights into deal structures
  • Due diligence - assess suitability of your proposed deal terms for partner companies
  • Save hundreds of hours of research time

Report Scope

Licensing Deals in Biotechnology is intended to provide the reader with an in-depth understanding of the licensing trends and structure of deals entered into by leading biopharma companies worldwide.

Licensing Deals in Biotechnology includes:

  • Trends in licensing dealmaking in the biopharma industry
  • Overview of licensing deal structure
  • Directory of licensing deal records covering pharmaceutical and biotechnology
  • The leading licensing deals by value
  • Most active licensing dealmakers
  • The leading licensing partnering resources

In Licensing Deals in Biotechnology, the available deals are listed by:

  • Company A-Z
  • Headline value
  • Therapeutic area
  • Technology type

Each deal title links via Weblink to an online version of the actual deal record, providing easy access to each contract document where available.

Licensing Deals in Biotechnology provides comprehensive access to available records for licensing deals, including contract documents where available.

Analyzing contract agreements allows due diligence of:

  • What are the rights granted or optioned?
  • What rights are granted by the agreement?
  • What exclusivity is granted?
  • What is the payment structure for the deal?
  • How are sales and payments audited?
  • What is the deal term?
  • How are the key terms of the agreement defined?
  • How are intellectual property rights handled and owned?
  • Who is responsible for commercialization?
  • Who is responsible for development, supply, and manufacture?
  • How is confidentiality and publication managed?
  • How are disputes resolved?
  • Under what conditions can the deal be terminated?
  • What happens when there is a change of ownership?
  • What sublicensing and subcontracting provisions have been agreed?
  • Which boilerplate clauses does the company insist upon?
  • Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
  • Which jurisdiction does the company insist upon for agreement law?

Companies Featured

  • 1cBio
  • 2seventy bio
  • 3B Pharmaceuticals
  • 3D Medicines
  • 3rd People's Hospital of Shenzhen
  • 3SBio
  • 3T Biosciences
  • 4D Molecular Therapeutics
  • 9 Meters Biopharma
  • 10X Genomics
  • 23andMe
  • 48Hour Discovery
  • 180 Life Sciences
  • A2 Biotherapeutics
  • Aadi Bioscience
  • Aardvark Therapeutics
  • Aarhus University
  • Aarvik Therapeutics
  • AAVnerGene
  • AazeinTx
  • AB2 Bio
  • Abbvie
  • Abcam
  • AbCellera Biologics
  • AbelZeta Pharma
  • Abeona Therapeutics
  • Abilita Therapeutics
  • Abintus Bio
  • ABL Bio
  • Ablexis
  • Abliva
  • Abound Bio
  • Aboundbio
  • Abpro
  • AbSci
  • AbTherx
  • ABT Innovations
  • ABVC BioPharma
  • ABX
  • ACADIA Pharmaceuticals
  • AC Bioscience
  • Accelerated Biosciences
  • Accelerate Technologies
  • AccuGenomics
  • Accurus Biosciences
  • AccuStem Sciences
  • ACEA Therapeutics
  • AcedrA BioPharmaceuticals
  • and many, many more!

For more information about this report visit https://www.researchandmarkets.com/r/cpi6fs

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Poland Investment Funds and Asset Management Market Report 2026, Profiles of TFI, Pekao, Santander, PKO, Allianz, Goldman Sachs - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Investment Funds and Asset Management Market in Poland, 2024-2026" report has been added to ResearchAndMarkets.com's offering. This report provides a comprehensive overview of the investment funds and asset management sector in Poland. Analysis covers the main pillars of the market, including: mutual funds, insurance, and pension assets. The report also mid-term forecast of key volumes for the period 2025-2027. The data has been presented in a form of horizontal pr...

Europe Data Center Colocation Market Outlook & Forecast Report 2025-2030 Featuring Major Players - Digital Realty, Equinix, NTT DATA, Global Switch, CyrusOne, Ark Data Centres - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Europe Data Center Colocation Market - Industry Outlook & Forecast 2025-2030" report has been added to ResearchAndMarkets.com's offering. The Europe Data Center Colocation Market was valued at USD 9.45 Billion in 2024, and is projected to reach USD 35.73 Billion by 2030, rising at a CAGR of 24.82%. The Europe data center colocation market is expected to witness cumulative investments of approximately $144.03 billion, of which, the Western Europe is slated to ac...

GCC Construction Equipment Market Research Report 2025-2030 Featuring Key Vendors - Caterpillar, Komatsu, Volvo, Hitachi, SANY, XCMG, JCB, Liebherr, Kobelco, and Zoomlion - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "GCC Construction Equipment Market Research Report 2025-2030" report has been added to ResearchAndMarkets.com's offering. The GCC Construction Equipment Market was sized at 68,499 Units in 2024, and is projected to reach 94,499 Units by 2030, rising at a CAGR of 5.51%. Governments in the UAE and Saudi Arabia continue to prioritize urban growth and diversification, with Dubai's long-term 2040 Urban Master Plan and the Saudi Vision 2030-linked mega-projects fuelling o...
Back to Newsroom